These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 9002124)

  • 21. Effect of quinolone prophylaxis in afebrile neutropenic patients on microbial resistance: systematic review and meta-analysis.
    Gafter-Gvili A; Paul M; Fraser A; Leibovici L
    J Antimicrob Chemother; 2007 Jan; 59(1):5-22. PubMed ID: 17077101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluoroquinolone resistance of Escherichia coli at a cancer center: epidemiologic evolution and effects of discontinuing prophylactic fluoroquinolone use in neutropenic patients with leukemia.
    Kern WV; Klose K; Jellen-Ritter AS; Oethinger M; Bohnert J; Kern P; Reuter S; von Baum H; Marre R
    Eur J Clin Microbiol Infect Dis; 2005 Feb; 24(2):111-8. PubMed ID: 15714332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Benzylpenicillin efficacy for neutropenic infection prophylaxis in patients with cancer and postcytostatic neutropenia].
    Minenko SV; Dmitrieva NV; Chimishkian KL; Zhukov NV; Sokolova EN; Larionova VB; Ptushkin VV
    Antibiot Khimioter; 2002; 47(7):13-9. PubMed ID: 12516191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemoprophylaxis of gram-negative infections in neutropenic patients.
    Klastersky J
    Eur Urol; 1990; 17 Suppl 1():40-5. PubMed ID: 2162299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of low dose ciprofloxacin on microbial colonization of the digestive tract in healthy volunteers during normal and during impaired colonization resistance.
    van de Leur JJ; Vollaard EJ; Janssen AJ; Dofferhoff AS
    Scand J Infect Dis; 1997; 29(3):297-300. PubMed ID: 9255893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ciprofloxacin prophylaxis during autologous stem cell transplantation for multiple myeloma in patients with a high rate of fluoroquinolone-resistant gram-negative bacteria colonization.
    Zavrelova A; Paterova P; Gabalec F; Zak P; Radocha J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2019 Jun; 163(2):161-165. PubMed ID: 30198521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ciprofloxacin prophylaxis in patients with acute leukemia and granulocytopenia in an area with a high prevalence of ciprofloxacin-resistant Escherichia coli.
    Gomez L; Garau J; Estrada C; Marquez M; Dalmau D; Xercavins M; Martí JM; Estany C
    Cancer; 2003 Jan; 97(2):419-24. PubMed ID: 12518366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activity of quinolones against viridans group streptococci isolated from blood cultures of patients with haematological malignancy.
    Kerr KG; Armitage HT; McWhinney PH
    Support Care Cancer; 1999 Jan; 7(1):28-30. PubMed ID: 9926971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluoroquinolone prophylaxis for bacterial infections in neutropenic patients with hematologic malignancies.
    Nenova IS; Ananostev NH; Goranov SE; Mateva NG; Haidushka IA
    Folia Med (Plovdiv); 2001; 43(4):40-5. PubMed ID: 12087953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A review of chemoprophylaxis and therapy of bacterial infections in neutropenic patients.
    Klastersky J
    Diagn Microbiol Infect Dis; 1989; 12(4 Suppl):201S-207S. PubMed ID: 2686921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emerging role of quinolones in the prevention of gram-negative bacteremia in neutropenic cancer patients and in the treatment of enteric infections.
    Bow EJ; Louie TJ
    Clin Invest Med; 1989 Feb; 12(1):61-8. PubMed ID: 2646056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibiotic prophylaxis in neutropenic patients: new evidence, practical decisions.
    Leibovici L; Paul M; Cullen M; Bucaneve G; Gafter-Gvili A; Fraser A; Kern WV
    Cancer; 2006 Oct; 107(8):1743-51. PubMed ID: 16977651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention of infections in neutropenic patients with pefloxacin.
    Meunier F
    J Antimicrob Chemother; 1990 Oct; 26 Suppl B():69-73. PubMed ID: 2258354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quinolone resistance in neutropenic patients: the effect of prescribing policy in the UK and Pakistan.
    Zaidi Y; Hastings M; Murray J; Hassan R; Kurshid M; Mahendra P
    Clin Lab Haematol; 2001 Feb; 23(1):39-42. PubMed ID: 11422229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluoroquinolone prophylaxis for the prevention of bacterial infections in patients with cancer--is it justified?
    Murphy M; Brown AE; Sepkowitz KA; Bernard EM; Kiehn TE; Armstrong D
    Clin Infect Dis; 1997 Aug; 25(2):346-8. PubMed ID: 9332551
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacokinetics and effects on bowel and throat microflora of oral levofloxacin as antibacterial prophylaxis in neutropenic patients with haematological malignancies.
    Timmers GJ; Dijstelbloem Y; Simoons-Smit AM; van Winkelhoff AJ; Touw DJ; Vandenbroucke-Grauls CM; Huijgens PC
    Bone Marrow Transplant; 2004 Apr; 33(8):847-53. PubMed ID: 14755314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiology of bloodstream infections in patients with acute myeloid leukemia undergoing levofloxacin prophylaxis.
    De Rosa FG; Motta I; Audisio E; Frairia C; Busca A; Di Perri G; Marmont F
    BMC Infect Dis; 2013 Dec; 13():563. PubMed ID: 24289496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Evaluation of antibiotic prophylaxis in neutropenic patients with hematologic malignancies].
    Delarive P; Baumgartner JD; Glauser MP; Cometta A
    Schweiz Med Wochenschr; 2000 Dec; 130(48):1837-44. PubMed ID: 11132527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Counterpoint: routine anti-bacterial prophylaxis is not indicated in neutropenic patients with hematological malignancies.
    Kleinberg M
    J Natl Compr Canc Netw; 2004 Sep; 2(5):445-51. PubMed ID: 19780253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rifampin does not improve the efficacy of quinolone antibacterial prophylaxis in neutropenic cancer patients: results of a randomized clinical trial.
    Gomez-Martin C; Solá C; Hornedo J; Perea S; Lumbreras C; Valentí V; Arcediano A; Rodriguez M; Salazar R; Cortés-Funes H; Hidalgo M
    J Clin Oncol; 2000 May; 18(10):2126-34. PubMed ID: 10811678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.